ReviewExperimental hematology & oncology2024

AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.

Niels Vandewalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.